M&A - ACCESS INDUSTRIES MANAGEMENT, LLC
Form Type: SCHEDULE 13D/A
Filing Date: 2025-05-23
Corporate Action: Merger
Type: Update
Accession Number: 000095017025076892
Filing Summary: Amendment No. 2 to Schedule 13D is filed by Access Industries Management, LLC, Access Industries Holdings LLC, AI ACEL LLC, and Len Blavatnik regarding common stock of ACELYRIN, INC. This amendment serves as an exit filing as the Reporting Persons completed a merger on May 21, 2025 per the Merger Agreement dated February 6, 2025. The Issuer merged with Alumis Inc. and resulted in the Issuer becoming a wholly owned subsidiary of Alumis. Each share of ACELYRIN, INC. common stock was converted into 0.4814 shares of Alumis common stock and cash for fractional shares. Post-merger, the Reporting Persons ceased to hold more than five percent of the Issuer's common stock and informed Nasdaq to suspend trading and requested delisting. The merger finalized the Reporting Persons' ownership and reporting obligations under applicable laws.
Additional details:
Item 4: Amendment No. 2 to Schedule 13D
Reporting Persons: Access Industries Management, LLC, Access Industries Holdings LLC, AI ACEL LLC, Len Blavatnik
Merger Date: 2025-05-21
Merger Agreement Date: 2025-02-06
Conversion Ratio: 0.4814
Post Merger Ownership: none
Nasdaq Request: suspend trading and delist shares
Exit Filing: true
Termination Of Registration: true
Form Type: SCHEDULE 13D/A
Filing Date: 2025-02-10
Corporate Action: Merger
Type: Update
Accession Number: 000095017025017188
Filing Summary: Access Industries Management, LLC and affiliated entities filed Amendment No. 1 to Schedule 13D on February 10, 2025, to disclose the acquisition of common stock of ACELYRIN, INC. and to report the execution of a Merger Agreement. On February 6, 2025, ACELYRIN, INC., Alumis Inc., and Arrow Merger Sub, Inc. entered into a Merger Agreement, where Merger Sub will merge into ACELYRIN, allowing ACELYRIN to become a wholly owned subsidiary of Alumis. As part of the merger, each share of ACELYRIN's Common Stock will convert into 0.4274 shares of Alumis Common Stock. The agreement anticipates stockholder ownership of approximately 45% for ACELYRIN and 55% for Alumis post-merger. The merger is contingent upon stockholder approval and satisfaction of certain conditions, including the effectiveness of a registration statement with the SEC. Voting Agreements have been established to facilitate the approval of the merger, where stockholders, including AI ACEL, will support the merger and related transactions.
Additional details:
Item Type: acquisition_date
Item Value: 2024-07-17
Item Type: exchange_ratio
Item Value: 0.4274
Item Type: post_merger_stockholder_distribution
Item Value: 45% ACELYRIN, 55% Alumis
Item Type: effective_time_description
Item Value: Merger results in ACELYRIN becoming a subsidiary of Alumis.
Item Type: listing_status
Item Value: ACELYRIN will no longer be listed on Nasdaq.
Item Type: conversion_of_equity_awards
Item Value: Converted Options, RSUs and PSUs convert to Alumis share equivalents based on the exchange ratio.
Comments
No comments yet. Be the first to comment!